Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs Vitamin E in Hyperuricemic NASH
NCT05574036Phase 2Active, not recruiting
- Sponsor
- Tanta University
- Start
- Aug 2022
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in Nonalcoholic steatohepatitis (NASH), sponsored by Tanta University. Started Aug 2022; status: active, not recruiting.
02
Drugs
febuxostat
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT05574036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05574036.